ILMN
$124.33-2.26 (-1.79%)
Illumina, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consu...
Recent News
ILMN Stock Gains Following Expanded Collaboration With Labcorp
Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer care.
How The Illumina (ILMN) Story Is Shifting With 2026 Expectations And Mixed Street Views
Illumina’s fair value estimate has been adjusted slightly, moving from US$135.94 to US$136.05, signaling only a very modest change in the modeled price target. That small shift sits against a backdrop of mixed analyst views, with some research teams lifting targets on the back of what they describe as improving end markets into 2026, while others worry that recent share moves already price in a stronger Q4 and 2026 setup. As you read on, you will see how these updates fit into the broader...
Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.
Illumina Stock Sees RS Rating Jump To 82
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Illumina stock cleared that benchmark Monday, with a jump from 77 to 82 Monday. Â Hone Your Stock-Picking Skills By Focusing On These Factors This unique rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
Assessing Illumina (ILMN) Valuation After Expanded Genomics And Proteomics Alliance With Regeneron
Illumina (ILMN) is back in focus after expanding its Alliance for Genomic Discovery with Regeneron Genetics Center and launching a dataset of more than 50,000 genomes plus proteomic data using Illumina Protein Prep, targeting multiomic drug discovery research. See our latest analysis for Illumina. Despite the latest alliance news, Illumina’s share price at US$118.94 reflects mixed momentum, with a 2.92% 1 day share price return but a 90 day share price return decline of 11.84%. The 1 year...